Clinical trial
Renin Angiotensin System Study (RASS/B-RASS)
NCT00143949 · Michael Mauer, MD, Other · Completed
Key facts
| NCT number | NCT00143949 |
|---|---|
| Title | Renin Angiotensin System Study (RASS/B-RASS) |
| Official title | Renin Angiotensin System Blockage-DN (RASS) |
| Lead sponsor | Michael Mauer, MD, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH Merck Sharp & Dohme LLC Industry Merck Frosst Canada Ltd. Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | enalapril, losartan |
| Enrollment | 285 |
| Start date | Mar 1, 1997 |
| Primary completion | Mar 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Sep 2, 2005 |
| Last update posted | Nov 6, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: